Public Health Pre Con: Future Therapies and Surveillance for Blood Disorders

NOT AVAILABLE FOR CREDIT

After a successful public health offering at NHF’s 2019 BDC, NHF decided to collaborate with several national blood disorder advocacy organization to deliver two public health sessions for chapters and consumers. This session will address the public health implications of future therapies and surveillance and was created by the Sickle Cell Community Consortium, National Blood Clot Alliance, Center for Inherited Bleeding Disorders, Cooley’s Anemia Foundation, Cure HHT, CDC, and NHF.